
==== Front
PLoS One
PLoS One
plos
PLOS ONE
1932-6203
Public Library of Science San Francisco, CA USA

10.1371/journal.pone.0307603
PONE-D-23-21892
Research Article
Medicine and Health Sciences
Medical Conditions
Noncommunicable Diseases
Biology and Life Sciences
Nutrition
Diet
Alcohol Consumption
Medicine and Health Sciences
Nutrition
Diet
Alcohol Consumption
Medicine and Health Sciences
Medical Conditions
Respiratory Disorders
Smoking Related Disorders
Medicine and Health Sciences
Pulmonology
Respiratory Disorders
Smoking Related Disorders
Medicine and Health Sciences
Mental Health and Psychiatry
Substance-Related Disorders
Smoking Related Disorders
Medicine and Health Sciences
Public and Occupational Health
Substance-Related Disorders
Smoking Related Disorders
People and Places
Geographical Locations
Asia
India
People and Places
Population Groupings
Age Groups
Adults
Elderly
Biology and Life Sciences
Psychology
Behavior
Habits
Smoking Habits
Social Sciences
Psychology
Behavior
Habits
Smoking Habits
Medicine and Health Sciences
Endocrinology
Endocrine Disorders
Diabetes Mellitus
Medicine and Health Sciences
Medical Conditions
Metabolic Disorders
Diabetes Mellitus
Medicine and Health Sciences
Public and Occupational Health
Tobacco Control
The effects of substance use on non-communicable diseases among older adults aged 60 and above in the North-eastern States of India
Effects of substance use on NCDs among Older adults aged 60 and above in the North-eastern States of India
https://orcid.org/0009-0002-4664-6926
Boro Sasanka Conceptualization Data curation Formal analysis Methodology Writing – original draft Writing – review & editing *
Saikia Nandita Supervision
Department of Public Health and Mortality Studies, International Institute for Population Sciences, Mumbai, India
Kumar Chandan Editor
TERI School of Advanced Studies, INDIA
Competing Interests: NO authors have competing interests.

* E-mail: boro485@gmail.com
10 9 2024
2024
19 9 e030760314 7 2023
9 7 2024
© 2024 Boro, Saikia
2024
Boro, Saikia
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

The North-eastern region of India has a relatively higher prevalence of substance use, which together with poor dietary practices and a lack of physical activity is one of the key risk factors for NCDs among older adults in the region. Understanding the prevalence of NCDs and their relationship to substance use can help develop preventive strategies and sensitization in North-eastern India.

Objective

To assess the prevalence of NCDs and the strength of the association of substance abuse among the geriatric population of North-eastern states in India, for the development of preventive strategies.

Methods

Data from the Longitudinal Ageing Study in India (LASI Wave-I, 2017–18) were drawn to develop this paper. The bi-variate and binary logistic regression analyses were carried out to predict the association between non-communicable diseases and substance use adjusting select socio-demographic characteristics.

Results

The paper revealed the prevalence of NCDs among urban people (61.45%) is higher than among rural people (42.45%). Hypertension (37.29%) can be seen as the most prevalent disease among the following given NCDs followed by Diabetes (8.94%). The chances of having Cancer are nineteen times higher (OR = 19.8; C.I. = 18.82–20.83) if an individual has past smoking behaviour after controlling for socio-demographic and physical activity variables.

Conclusion

Since, the high prevalence of hypertension correlated with the high level of substance abuse, require immediate attention to develop appropriate intervention strategies for its control (substance abuse) and prevention of hypertension. In a lower middle-income country like India, preventive measures, rather than curative measures will be cost-effective and helpful.

The authors received no specific funding for this work. Data AvailabilityThe data underlying the results presented in the study are available from (GATEWAY TO GLOBAL AGING DATA, https://g2aging.org/?section=lasi-downloads).
Data Availability

The data underlying the results presented in the study are available from (GATEWAY TO GLOBAL AGING DATA, https://g2aging.org/?section=lasi-downloads).
==== Body
pmcIntroduction

Epidemiological transition theory describes how the mortality and morbidity of a society change over time due to changes in social and economic conditions. It involves a shift from a predominance of communicable diseases as the leading causes of death to a predominance of non-communicable diseases, such as cardiovascular disease, cancer, and diabetes, typically associated with older age [1]. While the transition is driven by a range of social, economic, and environmental factors, demographic factors such as population ageing are key drivers. Population ageing demonstrates the shift in the age structure of a population over time due to fertility and mortality decline [2]. This shift is characterized by an increase in the proportion of people aged 60 and over, and a decrease in the proportion of young people. This changing age structure of a population has implications for health and wellbeing, particularly with regard to the increased burden of chronic diseases in an ageing population [3].

India along with other nations is going through unprecedented demographic changes, increased life expectancy and fertility decline have changed the age structure of India’s Older adults population, which is rapidly growing and emerging as a serious source of concern for the government and policymakers [4]. It not only gives extra years to survive but also serious health problems, as health conditions are more likely to occur in older age. The emergence of NCDs can be related to the population’s increased lifespan and are the most common, particularly among Older adults [5]. Thus, the goal should not be limited only to adding an extra number of years but to age healthily [6], healthy ageing is important in order to prevent the onset of NCDs and improve quality of life as people age [7]. As people age, their risk for developing NCDs increases, which can lead to reduced quality of life [8]. NCDs can also lead to physical and mental health problems, such as increased pain, fatigue, and depression [9]. Furthermore, unhealthy lifestyles, such as substance use, lack of physical activity, and unhealthy diets, can contribute to the development of NCDs and poor quality of life [10]. Therefore, it is essential to maintain healthy lifestyle habits in order to reduce the risk of NCDs and improve the quality of life.

Substance use is defined as the consumption of any psychoactive substance, such as tobacco, alcohol, or drug (legal or illicit drugs) other than those for medical use [11]. Previous literature found that substance consumption is one of the main factors for the burden of disease, disability, premature death, and non-communicable diseases (NCDs) among older adults. In most countries, it is a significant public health issue and is a challenging element of the overall healthcare system [12, 13]. In India, Alcohol (21.4%) was the primary substance used (apart from tobacco) followed by cannabis (3.0%) and opioids (0.7%) [14]. Numerous studies have been conducted to date that show high rates of tobacco and alcohol consumption, but no other study has attempted to link substance use to the occurrence of NCDs, Therefore, this study aims to investigate tobacco and alcohol use among older adults in north-east India. Specifically, the objective of this paper is to examine the associations of various non-communicable diseases with substance use, i.e., (1) NCDs and Ever smoked/smokeless tobacco use (2) NCDs and Ever-consumed Alcohol (3) NCDs and Current Smokers (4) NCDs and Current use smokeless tobacco products (5) NCDs and Current alcohol consumption.

Substance use as a risk factor for non-communicable diseases

Noncommunicable diseases (NCDs) include a wide range of diseases like cardiovascular diseases, cancer, diabetes, chronic respiratory diseases and neurological or psychiatric diseases which affect 41 million people annually and account for 71% of all deaths globally. Every year, more than 15 million people between the ages of 30 and 69 die due to an NCD. The low- and middle-income countries account for 85% of these "premature" deaths while they also account for 77% of all NCD deaths.

According to one study, tobacco use alone is responsible for one-sixth of all NCD-related deaths, while alcohol use accounts for more than two-thirds of all new cases of NCDs and raises the risk of complications in those who already have them, because of nicotine dependence, more than a billion people smoke or chew tobacco every day, and 15,000 people pass away from diseases associated with tobacco use [15].

Tobacco use, physical inactivity, harmful alcohol use, and poor dietary habits are the main risk factors of dying from an NCD [16]. India accounts for 5.87 million (60%) of all NCD-related fatalities, which accounts for more than two-thirds of all NCD-related deaths in the WHO’s South East Asia region. [17].

GATS [18] estimates that 266.8 million adults in India, who are 15 years of age and older, use tobacco in some way on a daily basis which accounts for 28.6% of them. In India, every tenth adult smokes tobacco, which amounts to 99.5 million people, and every fifth adult uses smokeless tobacco, which amounts to 199.4 million people, with the North-eastern area of the country displaying the highest prevalence of all the other states. [18]. Additionally, according to estimates from the World Health Organization (WHO), adult alcohol per capita consumption (APC) in India has significantly climbed from 2.4 liters, 4.3 liters, and 5.7 liters in 2005, 2010, and 2016 correspondingly [19].

Northeast India

Assam, Arunachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, Sikkim, and Tripura are the eight Indian states that represent Northeast India. Together, they are home to 3.8% of the nation’s total population, and of that, around 81.6% reside in rural areas [20].

A few small-scale studies found that the prevalence of substance use is higher in the North-eastern states of India [21–23]. According to a study conducted on the Mishing tribe in Assam, nearly half of the women consume alcohol, which is higher than the reported rate for women overall, substance use was very high in this population, with more than 60% of the population using alcohol and tobacco [24]. A national study shows the current tobacco usage among older adults with at least one chronic disease is significantly higher in the Northeast region (47.6%) in India [25].

According to a pilot study executed in Assam and Meghalaya, the prevalence of substance use in Assam and Meghalaya both was 29.4% tobacco (20.5% chewers and 12.7% smokers), 12.5% alcohol, and 4.9% opium. In Meghalaya, the prevalence of tobacco use was high (41.7%), mostly because there were so many male smokers and female chewers [26]. According to research by [27], more than half of adults in the states of Meghalaya, Manipur, Tripura, and Mizoram reported using tobacco at some point between 2009–2010 and 2012–2013. Meghalaya and Manipur also showed an increase in tobacco usage among women.

Studies have revealed that the North-eastern region of India has a lower overall prevalence of non-communicable diseases than the other regions of the country, however, the prevalence of CVD and Diabetes were high as compared with the central regions [28]. As substance consumption are leading behavioural and lifestyle risk factor for noncommunicable diseases all over the world, it is important to study how the increase in alcohol and tobacco consumption is influencing the burden of NCDs in the North-eastern states. Previous literature shows substance use and its association with noncommunicable diseases among adults and youth aged 15–54, however, there has not been any literature specifically on Older adults in the North-eastern region [23, 26, 29, 30]. This study includes age group from 60 and above i.e., older adults, because non-communicable diseases are most prevalent and common in these stages and their previous lifestyle behaviour comes into life by affecting the occurrence of these diseases.

Data and methodology

Data source

The study uses the Longitudinal Ageing Study in India (LASI) wave-1 Individual dataset to assess the prevalence and association of substance use and noncommunicable diseases among older adults aged 45 and above in the North-eastern states of India. The goal of LASI was to study a 45-year-old nationwide sample of India’s population. In order to give policymakers, the knowledge they need to enhance health and health behaviours in this demographic segment, the project is gathering information on the social, economic, and health circumstances of older people throughout India. Every two years for the next 25 years, a representative sample of the population aged 45 and older will be followed, together with their spouses, regardless of age, with refreshment samples to account for attrition due to death, dislocation, non-contact, and refusal. In Wave 1 of the LASI, 72,250 adults aged 45 and older and their spouses were included, including 31,464 older adults aged 60 and older and 6,749 oldest-old individuals aged 75 and older from 35 Indian states and union territories.

Socioeconomic and demographic variables

Socio-economic and Demographic variables namely Sex (Male and Female), Age Group (60–69, 70–79, and 80 and above), Place of residence (Urban and Rural), Caste (SC, ST, OBC, and Others), Religion (Hindu, Muslim, Christian, Buddhist, and Others), MPCE Quintile (Lowest, Lower, Middle, Higher, Highest), The assessment of monthly per capita consumption expenditure (MPCE) quintile was conducted utilizing household consumption data. Two sets of questions, comprising 11 for food and 29 for non-food items, were administered to sample households. Both food and non-food expenditures were standardized over a 30-day reference period. The MPCE was computed as the comprehensive measure of consumption. Subsequently, this variable was divided into five quintiles, ranging from the poorest to the richest. No. of years of education (No education, Less than 5 years of education, 5–9 years of education and 10 or more), Marital status (Currently married, Widowed, and Others), Work status (Currently working, Worked before but not currently working and never worked) were selected based on previous literature reviews.

Substance consumption and physical activity variables

We analyzed five dichotomous indicators of substance use viz. ever smoked/ used smokeless tobacco, ever consumed alcohol, currently consuming smokeless tobacco, currently consuming alcohol, currently smoking, and physical activity variable viz engaged in vigorous activities which are categorised into 5 categories (Every Day, more than once a week, once a week, one or three times a month, Hardly or never).

Dependent variable

In the process of data collection, information regarding 12 different self-reported chronic physical diseases and conditions (including hypertension, diabetes, cancer, chronic lung disease, chronic heart disease, stroke, arthritis, osteoporosis or other bone/joint diseases, neurological or psychiatric problems, hypercholesterolemia, thyroid disease, gastrointestinal problems, and chronic renal disease) was gathered and were coded as either "Yes" or "No" and was consequently used in our study.

Statistical analysis

Bivariate analyses are done to calculate the prevalence of those who have chronic diseases namely Hypertension, diabetes, cancer, lung disease, heart disease, high cholesterol, bone or joint disease, stroke and neurological/psychiatric diseases and lastly having any one of the following diseases by their socio-economic and demographic characteristics.

Since the dependent variables, i.e. NCDs are binary in nature, with only two categories–“Yes” and “No” and when the outcome variable is dichotomous in nature then binary logistic regression is the most commonly used model [31]. Thus, Binary logistic regression is used to identify significant relationships between ever-consumed substances and non-communicable diseases after controlling for the socio-economic and demographic variables among older adults aged 60 and above in the North-eastern states of India. The equation can be expressed as follows: logp1-p=β0+β1x1+β2x2+...+βnxn

Where p is the probability of occurrence of non-communicable disease, log is the natural logarithm, β0 is the intercept, β1, β2, …, βn are the coefficients associated with the predictor variables, x1 x2,…, xn.

Results

Sample description

Table 1 presents the descriptive statistics of the study population in addition to the characteristics of the Indian population to compare. Our sample consisted of 4155 individuals who were from the North-eastern states of India. Overall, the share of study participants was highest in the 60–69 age group, and males (52%) outnumbered females (48%). Most of the study population resided in rural areas (76%) and the majority of the study population belonged to the Christian religion (46%), followed by Hindus (39%). Only 11% of the participants had completed 10 or more years of education. 62% of the sample were currently married. More than half of the study participants were not engaged in work or had never worked before in the formal sector.

10.1371/journal.pone.0307603.t001 Table 1 Description of study population.

Background Characteristics	Northeast	India	
Frequency (n)	Percentage (%)	Frequency (n)	Percentage (%)	
Age Group	60–69	2,372	57.09	19,211	60.22	
	70–79	1,226	29.51	9,250	29	
	80+	557	13.41	3,441	10.79	
Sex	Male	2,004	48.23	15,340	48.08	
	Female	2,151	51.77	16,562	51.92	
Place of residence	Rural	3,145	75.69	21,085	66.09	
	Urban	1,010	24.31	10,817	33.91	
Caste	SC	301	7.24	5,157	16.17	
	ST	2,408	57.95	5,334	16.72	
	OBC	787	18.94	12,137	38.04	
	Others	659	15.86	9,274	29.07	
Religion	Hindu	1,609	38.72	23,292	73.01	
	Muslim	219	5.27	3,731	11.7	
	Christian	1,944	46.79	3,194	10.01	
	Others	1,609	9.22	1,685	5.28	
MPCE quintile	Lower	738	17.76	6,580	20.63	
	Lowest	834	20.07	6,573	20.6	
	Middle	876	21.08	6,502	20.38	
	Higher	876	21.08	6,259	19.62	
	Highest	831	20.00	5,988	18.77	
Education	No Education	2,167	52.15	17,190	53.89	
	Less than 5 years	720	17.33	3,835	12.02	
	5–9 years	804	19.35	6,065	19.01	
	10 or more years	464	11.17	4,811	15.08	
Marital Status	Currently Married	2,587	62.26	20,212	63.36	
	Widowed	1,417	34.10	10,845	33.99	
	Others	151	3.63	845	2.65	
Work Status	Currently working	1,442	34.71	9,373	29.39	
	Worked before	1,494	35.96	13,476	42.26	
	Never worked	1,219	29.34	9,038	28.34	
Total		4155	100	31,887	100	

Prevalence of non-communicable diseases by background characteristics

Fig 1 shows the state wise prevalence of non-communicable diseases among the older adults of North-eastern states of India, it can see that Sikkim has the highest share of people suffering from any NCD(65.89%) followed by Tripura(51.25%), Assam(48%), Manipur (46.72%), Mizoram (46.48%), Meghalaya (39.28%), Arunachal Pradesh (37.46%) and Nagaland (21.29%).

10.1371/journal.pone.0307603.g001 Fig 1 State wise prevalence of older adults aged 60 and above suffering from NCDs in the North-Eastern states of India, 2017–18.

It was observed that people suffering from various diseases have a previous history of tobacco consumption (smoking or smokeless tobacco) as follows: hypertension (48%), diabetes (42%), cancer (56%), lung diseases (69%), heart diseases (52%), high cholesterol (36%), stroke (54%), bone or joint diseases (48%), and neurological or psychiatric diseases (64%) (Fig 2). Additionally, the history of alcohol consumption among these individuals is: hypertension (21%), diabetes (23%), cancer (17%), lung diseases (27%), heart diseases (18%), high cholesterol (20%), stroke (37%), bone or joint diseases (20%), and neurological or psychiatric diseases (19%) (Fig 3).

10.1371/journal.pone.0307603.g002 Fig 2 Proportion of older adults aged 60 and above suffering from NCDs with past tobacco consumption behaviour.

10.1371/journal.pone.0307603.g003 Fig 3 Proportion of older adults aged 60 and above suffering from NCDs with past alcohol consumption behaviour.

Table 2 shows the prevalence of non-communicable disease by background characteristics and by state for people aged 60 and above in the North-eastern states and of India. Prevalence of all the NCDs among the urban people is higher than the rural people except cancer where it is more prevalent in the rural areas. Hypertension (37%) can be seen as the most prevalent disease among the following given NCDs followed by Diabetes (9%) then Bone or Joint Disease (7%) among the older adults of North-eastern states of India. ST older adults have less proportion suffering from Hypertension (29.04%), Diabetes (7.32%), lung diseases (3.56%), heart disease (1.83%), and Bone/Joint Disease (4.75%) compared with the other categories. The prevalence of the diseases for currently working people was less than for the people who were not working currently. It was observed that there was no clear pattern in the effect of education on the prevalence of all non-communicable diseases. However, our study found that individuals in the highest educational attainment category experienced greater levels of suffering compared to those with fewer years of education.

10.1371/journal.pone.0307603.t002 Table 2 Prevalence of non-communicable diseases by background characteristics among older adults aged 60 and above in the North-eastern states in India, 2017–18.

Background Characteristics	Hypertension	Diabetes	Cancer	Lung Disease	Heart Disease	High Cholesterol	Bone/Joint Disease	Stroke	Neuro/Psychiatric Disease	Any NCD	
Sex	Male	34.55	11.39	0.41	6.1	2.86	0.89	6.41	3.96	1.69	44.15	
	Female	39.63	6.85	0.57	3.81	4.25	1.08	7.49	1.71	2.69	48.27	
Age Group	60–69	34.02	9.13	0.66	3.87	3.47	1.23	6.51	2.63	2.24	43.06	
	60–75	39.98	8.77	0.27	5.29	3.87	0.66	7.98	2.61	2.35	49.42	
	75+	47.68	8.37	0.22	9.1	3.65	0.59	6.9	3.73	1.89	55.99	
Place of residence	Rural	34.24	7.1	0.54	4.75	2.7	0.32	6.27	2.03	1.73	42.45	
	Urban	49.04	16.03	0.34	5.34	7.1	3.57	9.76	5.51	4.18	61.45	
Caste	SC	35.76	12.13	0.72	7.91	9.26	0.17	5.69	0.65	2.44	47.33	
	ST	29.04	7.32	0.48	3.56	1.83	0.91	4.75	2.73	1.64	36.98	
	OBC	42.81	7.93	0.04	5.7	2.72	0.43	8.63	2.69	2.28	50.91	
	Others	41.13	10.68	0.92	4.42	4.58	1.94	8.18	3.54	2.76	51.63	
Religion	Hindu	40.27	9.49	0.39	5.58	4.12	1.08	6.93	2.8	2.29	49.13	
	Muslim	36.98	8.32	0.55	3.08	5.54	0	6.68	3.37	1.23	45.84	
	Christian	28.22	7.57	0.63	3.57	0.98	1.17	7.14	1.94	3.08	37.52	
	Others	30.77	8.23	1.4	5.16	0.69	1.96	8.21	3.38	0.99	42.99	
MPCE quintile	Lowest	28.79	4.19	0	4.99	2.19	0.76	2.78	0.87	0.42	34.49	
	Lower	35.07	5.52	0.19	3.19	2.73	0.26	5.86	3.51	0.52	44.85	
	Middle	41.65	12.28	0.38	6.04	4.21	0.61	5.24	2.37	4.65	51.61	
	Higher	40.3	10.81	0.03	5.84	3.83	0.85	8.81	2.68	2.27	49.23	
	Highest	41.62	12.94	2.1	4.53	5.45	2.81	13.34	4.42	3.71	52.75	
Education	No Education	31.91	4.52	0.27	5.04	2.67	0.31	6.72	2.19	1.86	40.96	
	Less than 5 years	40.23	11.06	0.15	4.14	4.52	0.16	4.86	1.51	1.36	47.51	
	5–9 years	39.78	9.16	0.92	5	4.37	1	6.94	2.78	2.92	48.76	
	10 or more years	48.92	21.77	1.05	4.91	4.65	4.39	10.59		3.51	60.4	
Marital Status	Currently Married	34.76	10.91	0.58	5.76	3.55	1.46	7.6	3.05	1.33	45.31	
	Widowed	41.26	6.14	0.41	3.81	3.74	0.15	6.28	2.43	3.59	48.54	
	Others	31.8	7.29	0	0	2.74	4.15	3.22	0.23	1.32	33.99	
Work Status	Currently working	27.33	6.5	0.06	3.29	1.88	0.72	5.71	1.47	0.65	34.19	
	Worked before	41.91	13.19	1.02	6.88	5.13	1.66	7.82	4.15	2.44	53.71	
	Never worked	41.39	6.14	0.29	3.96	3.45	0.44	7.23	2.29	3.53	49.31	
State	Assam	40.14	8.58	0.4	4.71	4.2	0.49	6.42	2.75	2.18	48	
	Meghalaya	35.6	5.52	0.19	1.96	1.39	1.05	4.39	0.76	1.42	39.28	
	Manipur	33.47	11.85	1.11	3.76	4.08	5.4	6.2	3.66	1.6	46.72	
	Mizoram	31.28	9.18	1.17	8.94	1.17	0.85	9.08	3.33	3.29	46.48	
	Tripura	36.67	10.65	0.7	9.35	3.81	0.87	10.76	3.95	2.52	51.25	
	Nagaland	15.1	6.8	0.08	1.02	0.37	0.37	3.61	1.39	5.33	21.29	
	Arunachal Pradesh	26.64	8.51	0.56	4.37	0.29	0	13.16	1.96	1.16	37.46	
	Sikkim	54.54	17.15	0	1.65	5.4	0.8	11.32	0.36	1.47	65.89	
Total		37.29	8.94	0.5	4.87	3.61	0.99	6.99	2.75	2.23	46.37	

Hypertension, Cancer, heart diseases, high cholesterol, bone or Joint Diseases and Neurological/Psychiatric Diseases were high among the older women than men.

Hypertension (54.54%), Diabetes (17.15%) and heart diseases (5.4%) were found to be highest in the state of Sikkim. Cancer is the highest in the State of Mizoram (1.17%). Lung Disease is the highest in the state of Tripura (9.35%). Whereas Neuro-Psychiatric Diseases can be seen highest in the state of Mizoram (2.35%).

Association between substance use and non-communicable diseases

Table 3 shows the binary logistic regression results of noncommunicable diseases with ever smoked or used tobacco products, ever consumed alcohol, currently smoking people, currently consuming tobacco products and currently consuming alcohol which is adjusted for physical activity, socioeconomic and demographic variables.

10.1371/journal.pone.0307603.t003 Table 3 Binary logistic regression output table of non-communicable diseases by substance consuming behaviour among older adults aged 60 and above in the North-eastern states of India, adjusted for physical activity, socio-demographic and economic variables, 2017–18.

Non-Communicable Diseases	0dds Ratio		Confidence Interval (95%)	
p-value	Lower Bound	Upper Bound	
Hypertension					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	1.39	0	1.379	1.401	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	1.338	0	1.327	1.349	
Currently Smokes					
 No®					
 Yes	0.719	0	0.713	0.726	
Currently use tobacco products					
 No®					
 Yes	0.816	0	0.809	0.822	
Currently consumes alcohol					
 No®					
 Yes	0.733	0	0.726	0.741	
Diabetes					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	0.917	0.006	0.905	0.929	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	2.157	0.014	2.13	2.184	
Currently Smokes					
 No®					
 Yes	1.087	0.008	1.071	1.103	
Currently use tobacco products					
 No®					
 Yes	0.963	0.006	0.951	0.975	
Currently consumes alcohol					
 No®					
 Yes	0.595	0.005	0.586	0.604	
Cancer					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	19.799	0	18.819	20.83	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	0.097	0	0.09	0.105	
Currently Smokes					
 No®					
 Yes	0.246	0	0.228	0.266	
Currently use tobacco products					
 No®					
 Yes	0.079	0	0.074	0.083	
Currently consumes alcohol					
 No®					
 Yes	1.231	0.01	1.051	1.443	
Lung Disease					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	2.316	0	2.28	2.352	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	0.702	0	0.689	0.715	
Currently Smokes					
 No®					
 Yes	0.532	0	0.522	0.542	
Currently use tobacco products					
 No®					
 Yes	0.48	0	0.472	0.487	
Currently consumes alcohol					
 No®					
 Yes	1.665	0	1.63	1.701	
Heart Disease					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	2.917	0	2.866	2.969	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	1.128	0	1.102	1.155	
Currently Smokes					
 No®					
 Yes	0.258	0	0.251	0.265	
Currently use tobacco products					
 No®					
 Yes	0.239	0	0.235	0.244	
Currently consumes alcohol					
 No®					
 Yes	1.87	0	1.821	1.921	
High Cholesterol					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	0.701	0	0.672	0.73	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	0.981	0.367	0.94	1.023	
Currently Smokes					
 No®					
 Yes	1.331	0	1.259	1.407	
Currently use tobacco products					
 No®					
 Yes	0.661	0	0.631	0.693	
Currently consumes alcohol					
 No®					
 Yes	0.316	0	0.292	0.342	
Bone or Joint Disease					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	1.095	0	1.079	1.111	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	1.216	0	1.197	1.236	
Currently Smokes					
 No®					
 Yes	0.607	0	0.595	0.618	
Currently use tobacco products					
 No®					
 Yes	0.793	0	0.781	0.804	
Currently consumes alcohol					
 No®					
 Yes	1.163	0	1.141	1.185	
Stroke					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	0.574	0	0.561	0.587	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	1.702	0	1.666	1.739	
Currently Smokes					
 No®					
 Yes	2.163	0	2.111	2.218	
Currently use tobacco products					
 No®					
 Yes	0.748	0	0.73	0.766	
Currently consumes alcohol					
 No®					
 Yes	0.338	0	0.327	0.349	
Neuro/Psychiatric Disease					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	3.599	0	3.515	3.685	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	1.408	0	1.372	1.444	
Currently Smokes					
 No®					
 Yes	0.755	0	0.732	0.78	
Currently use tobacco products					
 No®					
 Yes	0.849	0	0.83	0.869	
Currently consumes alcohol					
 No®					
 Yes	0.126	0	0.119	0.133	
Any NCD					
Ever smoked/smokeless tobacco use					
 Non smoker ®					
 Smoker	1.209	0	1.203	1.215	
Ever consumed Alcohol					
 Non drinker®					
 Drinker	1.239	0	1.231	1.247	
Currently Smokes					
 No®					
 Yes	0.683	0	0.677	0.689	
Currently use tobacco products					
 No®					
 Yes	0.728	0	0.722	0.733	
Currently consumes alcohol					
 No®					
 Yes	0.59	0	0.584	0.596	
Here ®: Reference Category

Ever Consumption of alcohol causes 1.33, 2.15 1.12, 1.21, 1.7, and 1.4 times more risk of suffering from Hypertension, Diabetes, Heart Diseases, Bone/Joint Disease, Stroke and Neuro/Psychiatric Diseases respectively as compared with individuals who have never consumed alcohol. Ever consumed Smoking and tobacco consumption creates 2.31 and 2.91 times more risk of lung diseases and heart disease respectively as compare with the non-smokers. Chances of having Cancer is 19.8 times more if individual has past smoking behaviour and Neuro and Psychiatric Disease has 3.56 times more that of non-smokers.

Odds of suffering from Any NCD if ever smoked or consumed smokeless tobacco is 1.20 and ever consumed alcohol is 1.23.

Currently smoking individuals have 1.08, 1.33 and 2.16 times higher odds of suffering from Diabetes, High Cholesterol and Stroke respectively and currently consuming alcohol individuals have 1.23, 1.66, 1.87 and 1.16 times more odds of suffering from Cancer, Lung Disease, Heart disease, Bone/Joint Disease respectively.

Discussion

The results of this study revealed the association between substance use and non-communicable diseases among older people in North-eastern states of India and demonstrated that smoking tobacco, consuming smokeless tobacco, and alcohol consumption were significantly related to poor health in this population. These findings are consistent with earlier research showing that older men and women who do not use any substance have lower rates of all-cause mortality, high blood pressure, diabetes, coronary heart disease, higher levels of cardiorespiratory and muscular fitness (lung diseases), and healthier body mass and composition than older people who use any kind of substance [32].

Findings reveal that the most important correlates of substance use are associated with the MPCE quintile and education i.e., with the increase in economic condition older adults are less likely to use any substance and with the increase in number of years of education people are less likely to use any kind of substance which supports prior studies that males, the uneducated, and the poor had a higher prevalence of tobacco use, which is problematic given that these individuals don’t have the necessary resources to take care the morbidity brought on by substance use [30, 33, 34]. From this study results reveal men exhibit a higher likelihood of using nearly all categories of substance compared to women, which also coincides with many literatures [35, 36]; furthermore, this characteristic is more prevalent among men in older ages [37]. SC and STs are less likely to consume substances than other caste groups [38], which shows that there is a significant direct relationship between socioeconomic class and education and alcohol intake in rural tribes. High levels of prevalence were identified in men, age groups of 60 years and above, followed by 30–39 years [39].

Moreover, findings reveal the prevalence of smokeless tobacco to be the highest in the North-eastern region of India which is in support of previous literature [40]. We also found that people residing in rural areas had a slightly higher tendency to use substances compared to the urban areas which is similar to a study [41].

Among all the other non-communicable diseases, hypertension was found to be most prevalent in our study in the North-eastern region [42]. Tripura, Mizoram, Assam, and Manipur were found to have the highest prevalence of using any kind of substance which is above the national average that have been discussed in other studies which may be accounted for the cultural set up in the region [27]. As reported by the United Nations Office on Drugs and Crime (UNODC), drug trafficking across the common border of Myanmar and the North-eastern states of India may have an impact on the increased substance use in these regions [43]. The study found the prevalence of non-communicable diseases in urban areas to be higher compared to rural areas which defends previous studies related to urban-rural differentials in the occurrence of non-communicable diseases [44]. Our study found that older adults who are widowed have a greater likelihood of developing non-communicable diseases compared to those who are currently married. This may be attributed to the fact that many widowed older adults are women, who are more prone to chronic illnesses and may turn to substance use as a way to cope with loneliness and grief [45, 46]. Our study identified significant positive relationships between Lung Disease, Heart Disease, High Cholesterol and smoking behaviour which is in support of previous literature which was conducted in Kerala on the prevalence of coronary heart diseases (CHD), they found high prevalence rates of four risk factors, viz. hypertension, smoking, diabetes, and obesity, where the median age of initiation for both smoking behaviours and alcohol use was 21 years, and nearly two fifths (40%) of the sample population were current smokers and users of alcohol (41%) [47] and also it has been shown earlier that tobacco use and alcohol consumption were the most common risk factors for NCDs among rural tribal adults in Mokokchung district of Nagaland [48]. A study found that the most frequent causes of death in older individuals have been clearly connected to tobacco smoking, which also increases the morbidity and impairment due to several diseases that are prevalent in this age range [49].

Our study also found that with the consumption of alcohol, there is a higher risk of having health problems like Hypertension, Diabetes, Heart Diseases, Bone/Joint Diseases, and Neurological/Psychiatric Diseases, these findings are similar to other studies [50].

Given the growing prevalence of chronic diseases in the aging population of North-eastern states in India, efforts to prevent chronic diseases and improve health behaviours are needed in the region. A step has been initiated by the Government of India for control and prevention of the highly occurring non-communicable diseases such as Cancer Diabetes, Cardiovascular diseases, and Stroke [51].

Alcohol and tobacco control policies

Worldwide, there are national alcohol rules in existence in 66 nations. Aside from Bangladesh, Indonesia, and the Maldives, three Muslim nations in Southeast Asia where alcohol drinking is either entirely or partially prohibited in accordance with Islamic belief. The National Authority on Tobacco and Alcohol (NATA) Act of Sri Lanka, which was enacted in 2006, and the Alcohol Beverage Control Act B.E. 2551 of Thailand, which was established in 2008, are the only countries having alcohol policy frameworks in place [52].

In India, numerous tobacco control laws and regulations have been passed in an effort to reduce the incidence such as the Cigarettes Act 1975 (Regulation of Production, Supply, and Distribution), Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply, and Distribution) Act (COTPA) in 2003, Prevention of Food Adulteration Act (PFA) (Amendment) 1990, Cigarettes and other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply, and Distribution) Amendment Rules, 2023, etc. for paan masala and chewing tobacco [53] and for alcohol, the legal drinking age ranges from 18 to 25 years of age, and state-by-state alcohol taxation rates ranging from 30% to 100% on alcoholic beverages are all examples of alcohol control policies. Alcohol is also prohibited in four Indian states and the union territory of Lakshadweep [54].

Additionally, India joined the WHO Framework Convention on Tobacco Control (FCTC) in 2005 as well. In order to manage and control tobacco consumption, WHO introduced MPOWER, for Monitoring tobacco use and prevention policies, protecting people from tobacco smoke, offering help to quit tobacco use, warning about the danger of tobacco, enforcing a ban on tobacco advertising and promotion, and raise taxes on tobacco products. In its National Health Policy published in 2017, the Indian government aims to reduce tobacco consumption by 30 percent on a relative basis by the year 2025.

However, despite everything, substance usage is still pervasive in India [55]. Consequently, it begs important questions like, "Why does it happen this way?" In this context, we attempt in a straightforward manner to analyse the prevalence of NCDs at different levels and their relationship to substance usage among older adults (aged 60+) in the North-eastern states of India. Some major SDG’s under which governments are taking steps and suggesting the importance of controlling alcohol and tobacco consumption for the better sustainability of humans are:

SDG 3.a: Strengthen the WHO Convention on Tobacco in all countries.

SDG Target 3.5: Strengthen prevention and treatment of substance abuse.

SDG Target 3.4: By 2030 reduce by one-third pre-mature mortality from non-communicable diseases

Efforts to sensitize people about their consumption behaviour must not be stopped and acts like COTPA must be strengthened and continued, which has important provisions such as: no smoking of tobacco in public places, promotion or advertisement of tobacco product is prohibited, the age limit of 18 years and tobacco products should be sold with graphical warnings on tobacco packets like “Smoking Kills, It causes Cancer”. The National Tobacco Control Program was also established in accordance with the provisions of COPTA. It offers a globally coordinated response to the tobacco epidemic and lays out specific guidelines for government action, such as tax and price measures, bans on tobacco advertising, promotion, and sponsorship, smoke-free zones, etc. It is one of the seven priority areas of NHP, where both preventive and promotive health care is required to achieve sustainable health.

Limitation of the study

The study focuses on the association between substance use and non-communicable diseases by the different background characteristics using the longitudinal data, but since only 1st wave has been done so far thus it acts as a cross-sectional study and hence no causal relationship has been inferred from the current study. The study is based on the self-reported chronic disease data that may cause the over or under-estimation in the study since there was no metabolic biomarkers data to support risk/association. The study also is based on self-reported consumption of substances which can also hamper our estimations. Moreover, our study was unable to delve into the specific levels of substance consumption behavior. Assessing the risk requires information on the quantity, frequency, and duration of smoking, substance use, and alcohol consumption. Unfortunately, such detailed data is not accessible; only binary responses in the form of "yes" or "no" are available. The study couldn’t focus separately on ever-consumed smokeless tobacco and smoking as there was no data, the study also didn’t focus on the current consumption of substances in association with non-communicable diseases due to data limitations. Muslim and SC samples are very low as compared to their counterpart in the region, hence it may produce bias in the results. Household consumption which could have been incorporated was not considered because most substance in north northeast region is locally produced and can hamper our study.

Conclusion and scope of the study

We can conclude that substance use is highly associated with non-communicable diseases in the North-eastern region’s older adult population. Our findings reveal much room for improvement in older North-eastern Indians’ health behaviours. High tobacco and alcohol use among people aged 60+ with chronic diseases like CVDs, lung diseases, and diabetes is alarming. Prioritizing alcohol reduction, smoking cessation, and physical activity in public health is essential. All over, study shows that people at older age diagnosed with chronic illness are still consuming tobacco and alcohol at high proportion. Few studies have shown that Older adults’ not only have higher rate of nicotine dependence but also they are more resistant to quitting [56, 57]. Thus, nothing is impossible as these behaviours are modifiable, hence our findings have important implications for health policy in India. This study will contribute to existing knowledge by examining different factors among older adults aged 60 and we believe it will help us give insight not only into their health associated with their lifestyle behaviours but also it will further help the government implementation of effective policies and programmes for the welfare of older adults.

Efforts to reduce smoking, alcohol, and tobacco consumption among older men are needed like awareness programmes workshops, camps, community discussions, etc. at the community level must be entertained. Also, cultural activities to sensitize the negative impact of substance use may be performed regularly to spread awareness. A complete ban is always not possible as the study region is mainly rural, the substance is locally available, and less expensive as compared with the imported substances. Improved health behaviours are expected to improve health outcomes and prevent or delay the onset of disabilities and chronic diseases. Based on these findings, we recommend the development and implementation of educational and interventional programs to improve health behaviours. These programs may be customized for various groups (e.g., more- and less-educated people, men, and women).

Abbreviations

COTPA Cigarettes and other Tobacco Products Act

CVD Cardiovascular Diseases

DHS Demographic and Health Surveys

FCTC Framework Convention on Tobacco Control

GATS Global Adult Tobacco Survey

LASI Longitudinal Aging Survey of India

MDG Millennium Development Goals

MPCE Monthly per Capita Expenditure

NCDs Non-Communicable Diseases

NE North East

NFHS National Family and Health Survey

SDG Sustainable Development Goals

STATA Statistics and Data

UN United Nations

UNDP United nations Development Programme

WHO World Health Organisation

10.1371/journal.pone.0307603.r001
Decision Letter 0
Kumar Chandan Academic Editor
© 2024 Chandan Kumar
2024
Chandan Kumar
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Submission Version0
12 Dec 2023

PONE-D-23-21892The Effects of Substance Use on Non-Communicable Diseases among Older Adults Aged 60 and Above in the North-eastern States of IndiaPLOS ONE

Dear Dr. Boro,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 26 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Chandan Kumar, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: To

The Authors

The Authors prepared the present communication based on the secondary data 'Longitudinal Ageing Study in India (LASI Wave-I, 2017–18)', which was carried out in 35 States/UTs. Why the authors have taken data for only Northeastern states?

The authors looked into the factors responsible for high incidence or prevalence of NCDs including tobacco smoking, substance use, physical inactivity etc.

Methodology

There is need to obtain the data with a specific objective, which is not given in the manuscript. Several disease variable were addressed here, but there no specific definitions for each these variables

In the introduction, it is given like India is a low income country. In fact, India is not low income country. This may be deleted. India is lower middle income country.

How monthly per capita income was collected, which may not be always correct

Quantity, frequency and duration of smoking, substance use, alcohol consumption is very important to estimate the risk, but this kind of data is not available - only except yes or No.

The major drawback in this database, no metabolic biomarkers data to support risk/association

Some of the editorial corrections needed here and there in the text

All the dependent variables collected in the main survey was based on the reported data, which may not be a correct data. At least the data collection on morbidity/mortality should be based on the medical reports/statutory reports

Discussion: May be pruned to precise

The weakness and strengths of the study needs to be mentioned

Conclusions

The conclusions should be focused and should be based on the data

Tables

Table 1 & 2 may be clubbed

Reviewer #2: 1. You can add new tobacco, alcohol, and drugs related policies in the policy section.

2. There has been requirement to highlight the gaps in the former works and say clearly why you are focusing in this field.

3. I think adding the mathematical formulae of Logistic regression would give the study a statistical robustness.

4. In your abstract please edit the results section and explain the abbreviations which are entered in your whole text.

5. Your method part needs to rewrite in extended form.

6. Need to write justification behind the applied statistical analysis. Add justification as of why you have used binary logistic regression.

7. Discussion part need to add some powerful previous works and compare the differences and discuss on them.

8. Add the international classification of disease codes for the diseases that you have selected

9. Literature review and rationale of the need to be improve. Please read this article and cite it in literaure review section (https://doi.org/10.1080/14659891.2022.2146014).

10. How the authors addressed the contribution of other confounding variables in the outcomes of the study.

11. there are several grammatical errors, which need to be fixed before publication.

12. Presentaion of the odds ration should be standard.

13. Please correct it ( line 320, St’s were less likely to consume all kinds)

14. Please try to avoid We, I, you etc. from the manuscript (We found that the most important correlates)

15. I suggests authors to rewrite the discussion section based on key findings only, how its similar or dissimilar with previous study and why?

16. In your study Muslim and SC sample is very low as compared to their counterpart, the results could be biased.

17. A age group specific analyses could be helpful to understand the result better way. It we see the previous results with increasing age the odds of your selected outcome variables is higher than their counterparts. So you could think about it.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Avula Laxmaiah, Former Senior Public Health Nutrition scientist, ICMR-National Institute of Nutrition

Reviewer #2: Yes: Margubur Rahaman

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0307603.r002
Author response to Decision Letter 0
Submission Version1
9 Feb 2024

Reviewer #1: To

The Authors

The Authors prepared the present communication based on the secondary data 'Longitudinal Ageing Study in India (LASI Wave-I, 2017–18)', which was carried out in 35 States/UTs. Why the authors have taken data for only Northeastern states?

Response: We selected the north-eastern states based on previous literature. As indicated in the north-east sub-section on page 4, prior research has identified a higher prevalence in this region.

The authors looked into the factors responsible for high incidence or prevalence of NCDs including tobacco smoking, substance use, physical inactivity etc.

Response: Certainly, as outlined in paragraph 3 of the introduction section on page 3, line 121, these factors are acknowledged in the literature as significant contributors to the onset of non-communicable diseases in older age. Therefore, we have duly taken these four elements into consideration

Methodology

There is need to obtain the data with a specific objective, which is not given in the manuscript.

Response: Certainly, we have added the specific objective at the end of introduction section in the page number 2 line 128.

Several disease variable were addressed here, but there no specific definitions for each these variables

Response: We have added the definition each of our disease(dependent) variable in the dependent variable section of methodology part in the page number 6 line 243.

In the introduction, it is given like India is a low income country. In fact, India is not low income country. This may be deleted. India is lower middle income country.

Response: Certainly, we have corrected the mistake in the conclusion section of the abstract in line 72 of page no. 2.

How monthly per capita income was collected, which may not be always correct

Response: We have added how MPCE quintile in LASI has been calculated in the socio-economic and demographic variables section of methodology part in the page number 6 line 218.

Quantity, frequency and duration of smoking, substance use, alcohol consumption is very important to estimate the risk, but this kind of data is not available - only except yes or No.

Response: Yes, we have mentioned this into the limitations section in or study in page number 11 of line 465.

The major drawback in this database, no metabolic biomarkers data to support risk/association

Response: Certainly, we have mentioned this into the limitations section in or study in page number 11 of line 463.

Some of the editorial corrections needed here and there in the text.

Response: We have edited the manuscript and checked for editorial errors.

All the dependent variables collected in the main survey was based on the reported data, which may not be a correct data. At least the data collection on morbidity/mortality should be based on the medical reports/statutory reports

Response: Yes, this problem statement has been discussed in the limitation section in page number 11.

Discussion: May be pruned to precise

Response: Yes, we have edited the discussion section.

The weakness and strengths of the study needs to be mentioned

Response: Yes, we have given a separate limitation section in page number 11.

Conclusions

The conclusions should be focused and should be based on the data

Response: Yes, the conclusion has been edited and was focused based on our data and findings.

Tables

Table 1 & 2 may be clubbed

Response: Thank you, the distinction between Table 1 and Table 2 lies in their content: Table 1 provides a description of our study variables, while Table 2 focuses on the prevalence of all Non-Communicable Diseases (NCDs). We made a conscious decision to present them separately to enhance clarity and ensure a more organized presentation of our findings.

Reviewer #2:

1. You can add new tobacco, alcohol, and drugs related policies in the policy section.

Response: Yes, we have added the COTPA amendment rules in the policy section of page number 10 and line number 419.

2. There has been requirement to highlight the gaps in the former works and say clearly why you are focusing in this field.

Response: Yes, we have mentioned this in the north-east India section page number 5 and line number 191.

3. I think adding the mathematical formulae of Logistic regression would give the study a statistical robustness.

Response: Yes, we have added the mathematical formulae for binary logistic regression in the statistical analysis section of page number 7 in line number 260.

4. In your abstract please edit the results section and explain the abbreviations which are entered in your whole text.

Response: Yes, we have added the abbreviations in the appendix of the manuscript.

5. Your method part needs to rewrite in extended form.

Response: Certainly, the method section has been revised to provide concise and clear explanations, facilitating a more straightforward understanding of the study.

6. Need to write justification behind the applied statistical analysis. Add justification as of why you have used binary logistic regression.

Response: Yes, we have added the justification behind the usage of binary logistic regression in the statistical analysis section in the page number 6, line number 255.

7. Discussion part need to add some powerful previous works and compare the differences and discuss on them.

Response: Yes, we have added few previous studies to felicitate our findings namely:

1. M. A. Kumar MS, Oinam A, Mukherjee D, Kishore K, “Women who use drugs in NorthEast India,” vol. 25, no. 4, pp. 343–349, 2015, [Online]. Available: https://www.unodc.org/documents/southasia//publications/research-studies/FINAL_REPORT.pdf

2. S. P. Marbaniang, H. S. Chungkham, and H. Lhungdim, “A structured additive modeling of diabetes and hypertension in Northeast India,” PLOS ONE, vol. 17, no. 1, p. e0262560, Jan. 2022, doi: 10.1371/journal.pone.0262560.

3. M. K. Gupta, D. A. Nagdeve, D. Mahata, and H. Chaurasia, “Substance Abuse Among Elderly in India: Evidence Based on Study on Global Ageing and Adult Health (SAGE) Wave 1,” Glob. Soc. Welf., pp. 1–7, 2023

4. M. E. Patrick, P. Wightman, R. F. Schoeni, and J. E. Schulenberg, “Socioeconomic status and substance use among young adults: a comparison across constructs and drugs,” J. Stud. Alcohol Drugs, vol. 73, no. 5, pp. 772–782, 2012

5. R. K. McHugh, V. R. Votaw, D. E. Sugarman, and S. F. Greenfield, “Sex and gender differences in substance use disorders,” Clin. Psychol. Rev., vol. 66, pp. 12–23, 2018.

8. Add the international classification of disease codes for the diseases that you have selected

Response: Certainly, we could have added it but LASI survey does not provide us with the ICD codes hence we would be unable to provide it and hence it has been also added in the limitation section however the variable definition have been added in the dependent variable section of methodology part in the page number 6 and line number 243 for better explanation of the disease variables.

9. Literature review and rationale of the need to be improve. Please read this article and cite it in literaure review section (https://doi.org/10.1080/14659891.2022.2146014).

Response: Thank you for the suggestion, we have added the literature in the north east section to provide rationale to our study in page number 5 in line number 173.

10. How the authors addressed the contribution of other confounding variables in the outcomes of the study.

Response: To adjust for confounding variables, confounding factors such as age, education, marital status, monthly per capita consumption expenditure (MPCE), religion etc. were adjusted in the final model.

11. there are several grammatical errors, which need to be fixed before publication.

Response: Yes, the manuscript has been re-checked for grammatical errors.

12. Presentation of the odds ration should be standard.

Response: I appreciate your feedback and the attention you've given to the presentation of odds ratios in our paper. Your suggestion to adhere to a standard format is duly noted, and I want to express our gratitude for your valuable input. However, after careful consideration, we have deliberately chosen a specific presentation style for the odds ratios in line with the nuances and objectives of our study. We understand that there are various ways to present odds ratios, and we respect the suggestion for a standard format. Yet, we firmly believe that our chosen approach is the most effective for conveying the nuances of our study.

13. Please correct it ( line 320, St’s were less likely to consume all kinds)

Response: Thank you for your careful attention, we have corrected the typing error.

14. Please try to avoid We, I, you etc. from the manuscript (We found that the most important correlates)

Response: Certainly, we have edited the manuscript and tried to avoid the We and I to the best we can.

15. I suggests authors to rewrite the discussion section based on key findings only, how its similar or dissimilar with previous study and why?

Response: Yes, the discussion has been revised to focus on key findings, incorporating previous literature reviews to highlight similarities and differences with prior studies.

16. In your study Muslim and SC sample is very low as compared to their counterpart, the results could be biased.

Response: Thank you for the keen observation , the study has been focused in the north-eastern parts of India and according to LASI dataset the sample of Muslim and SC population is low in the region and hence we have added this as one of the limitations in our study.

17. A age group specific analyses could be helpful to understand the result better way. It we see the previous results with increasing age the odds of your selected outcome variables is higher than their counterparts. So you could think about it.

Response: Thank you for your insightful comment and suggestion regarding age-specific analyses. I appreciate your attention to detail. While I acknowledge the potential value of age-specific analyses in enhancing our understanding, regrettably, conducting such analyses goes beyond the scope of the current paper. Our primary focus was on associating NCDs with substance use among the elderly itself i.e. 60 and beyond. However, I genuinely appreciate your suggestion, and it is duly noted for future research considerations.

Attachment Submitted filename: Response to reviewers.docx

10.1371/journal.pone.0307603.r003
Decision Letter 1
Kumar Chandan Academic Editor
© 2024 Chandan Kumar
2024
Chandan Kumar
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Submission Version1
3 May 2024

PONE-D-23-21892R1The Effects of Substance Use on Non-Communicable Diseases among Older Adults Aged 60 and Above in the North-eastern States of IndiaPLOS ONE

Dear Dr. Boro,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that the revised manuscript still has to undergo a minor modification. Authors are thus advised to go through the comments given in the attached file of the manuscript, and submit the revised version of the manuscript after incorporating the comments/suggestions and undergoing a thorough language editing.

Please submit your revised manuscript by Jun 17 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Chandan Kumar, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Reviewers' comments:

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Abstract:

Objective: To assess the prevalence of NCDs and strength of association of substance abuse among geriatric population of Northeastern states in India, for the development of preventive strategies, but not for implementation.

Methods:

Data received from the 'Longitudinal Ageing Study in India' (LASI -wave 1 2017-18) for the present communication (paper), not for the study.

Conclusion:

Since, high prevalence of hypertension correlated with the high level of substance abuse, require immediate attention to develop an appropriate intervention strategies for its control (substance abuse) and prevention of hypertension.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Avula Laxmaiah, Former Director grade scientist, ICMR-National Institute of Nutrition, Hyderabad, India

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0307603.r004
Author response to Decision Letter 1
Submission Version2
19 May 2024

The abstract has been changed as advised

Attachment Submitted filename: Response to Reviewers.docx

10.1371/journal.pone.0307603.r005
Decision Letter 2
Kumar Chandan Academic Editor
© 2024 Chandan Kumar
2024
Chandan Kumar
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Submission Version2
25 Jun 2024

PONE-D-23-21892R2The Effects of Substance Use on Non-Communicable Diseases among Older Adults aged 60 and above in the North-eastern States of IndiaPLOS ONE

Dear Dr. Boro,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that the manuscript has not yet met PLOS ONE’s publication criteria. There is need for a thorough language (English) editing of the manuscript. Please refer to some of the comments, highlighted texts (in yellow colour), and edits (in track change mode) given in the attached copy of your revised manuscript. We invite you to submit a revised version of the manuscript that addresses the points raised in the attached copy of the manuscript.

Please submit your revised manuscript by Aug 09 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Chandan Kumar, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment Submitted filename: Manuscript_Editors comments.docx

10.1371/journal.pone.0307603.r006
Author response to Decision Letter 2
Submission Version3
3 Jul 2024

Yes we have incorporated all the changes as advised by the editor and checked the figures in PACE.

Attachment Submitted filename: Response to Reviewers.docx

10.1371/journal.pone.0307603.r007
Decision Letter 3
Kumar Chandan Academic Editor
© 2024 Chandan Kumar
2024
Chandan Kumar
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Submission Version3
9 Jul 2024

The Effects of Substance Use on Non-Communicable Diseases among Older Adults aged 60 and above in the North-eastern States of India

PONE-D-23-21892R3

Dear Dr. Boro,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Chandan Kumar, Ph.D.

Academic Editor

PLOS ONE

10.1371/journal.pone.0307603.r008
Acceptance letter
Kumar Chandan Academic Editor
© 2024 Chandan Kumar
2024
Chandan Kumar
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
30 Aug 2024

PONE-D-23-21892R3

PLOS ONE

Dear Dr. Boro,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chandan Kumar

Academic Editor

PLOS ONE
==== Refs
References

1 Santosa A. , Wall S. , Fottrell E. , Högberg U. , and Byass P. , “The development and experience of epidemiological transition theory over four decades: a systematic review,” Glob. Health Action, vol. 7 , no. 1 , p. 23574, Dec 2014, doi: 10.3402/gha.v7.23574 24848657
2 J. R. Goldstein, “How Populations Age BT—International Handbook of Population Aging,” P. Uhlenberg, Ed. Dordrecht: Springer Netherlands, 2009, pp. 7–18.
3 Strong K. , Mathers C. , Leeder S. , and Beaglehole R. , “Preventing chronic diseases: how many lives can we save?,” Lancet, vol. 366 , no. 9496 , pp. 1578–1582, 2005, doi: 10.1016/S0140-6736(05)67341-2 16257345
4 Agarwal A. , Lubet A. , Mitgang E. , Mohanty S. , and Bloom D. E. , “Population Aging in India: Facts, Issues, and Options BT—Population Change and Impacts in Asia and the Pacific,” Poot J. and Roskruge M. , Eds. Singapore: Springer Singapore, 2020, pp. 289–311.
5 Himanshu and B. Talukdar, “Prevalence of Multimorbidity (Chronic NCDS) and Associated Determinants Among Elderly in India,” Demogr. India, p. Table 1, Page 74, 2017, [Online]. https://www.researchgate.net/profile/Himanshu-Himanshu/publication/324015609_Prevalence_of_Multimorbidity_Chronic_NCDS_and_Associated_Determinants_Among_Elderly_in_India/links/5ac1c698a6fdcccda65df461/Prevalence-of-Multimorbidity-Chronic-NCDS-and-Associat
6 C. M. Black, Working for a healthier tomorrow: Dame Carol Black’s review of the health of Britain’s working age population. Stationery Office, 2008. [Online]. https://books.google.co.in/books?id=1YylXQOWvrYC
7 W. H. Organization, Global action plan for the prevention and control of noncommunicable diseases 2013–2020. World Health Organization, 2013.
8 A. Bowling, Ageing well: Quality of life in old age. McGraw-hill education (UK), 2005.
9 Prince M. et al. , “No health without mental health,” Lancet, vol. 370 , no. 9590 , pp. 859–877, 2007. doi: 10.1016/S0140-6736(07)61238-0 17804063
10 Moral-García J. E. , Agraso-López A. D. , Ramos-Morcillo A. J. , Jiménez A. , and Jiménez-Eguizábal A. , “The influence of physical activity, diet, weight status and substance abuse on students’ self-perceived health,” Int. J. Environ. Res. Public Health, vol. 17 , no. 4 , p. 1387, 2020. doi: 10.3390/ijerph17041387 32098096
11 W. H. Organization, Neuroscience of psychoactive substance use and dependence. World Health Organization, 2004.
12 Nyhlén A. , Fridell M. , Bäckström M. , Hesse M. , and Krantz P. , “Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970–2006,” BMC Psychiatry, vol. 11 , no. 1 , p. 122, 2011, doi: 10.1186/1471-244X-11-122 21801441
13 McGill V. , Kowal-Vern A. , Fisher S. G. , Kahn S. , and Gamelli R. L. , “The Impact of Substance Use on Mortality and Morbidity from Thermal Injury,” J. Trauma Acute Care Surg., vol. 38 , no. 6 , 1995, [Online]. https://journals.lww.com/jtrauma/Fulltext/1995/06000/The_Impact_of_Substance_Use_on_Mortality_and.19.aspx doi: 10.1097/00005373-199506000-00019 7602638
14 Dhawan A. , Rao R. , Ambekar A. , Pusp A. , and Ray R. , “Treatment of substance use disorders through the government health facilities: Developments in the ‘Drug De-addiction Programme’ of Ministry of Health and Family Welfare, Government of India,” Indian J. Psychiatry, vol. 59 , no. 3 , p. 380, 2017. doi: 10.4103/psychiatry.IndianJPsychiatry_19_17 29085101
15 Beaglehole R. et al. , “Priority actions for the non-communicable disease crisis,” Lancet, vol. 377 , no. 9775 , pp. 1438–1447, 2011. doi: 10.1016/S0140-6736(11)60393-0 21474174
16 World Health Organization, “Noncommunicable diseases key facts,” World Heal. Organ., no. April, p. 8, 2021, [Online]. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
17 Nethan S. , Sinha D. , and Mehrotra R. , “Non Communicable Disease Risk Factors and their Trends in India,” Asian Pac. J. Cancer Prev., vol. 18 , no. 7 , pp. 2005–2010, Jul 2017, doi: 10.22034/APJCP.2017.18.7.2005 28749643
18 Ministry of Health & Family Welfare Government of India, Global Adult Tobacco Surey 2016–2017, vol. 1, no. 1. 2017. [Online]. https://mohfw.gov.in/sites/default/files/GlobaltobacoJune2018.pdf
19 Hammer J. H. , Parent M. C. , Spiker D. A. , and World Health Organization, Global status report on alcohol and health 2018, vol. 65 , no. 1 . 2018.
20 I. Registrar General & Census Commissioner, “Census of India: Population Enumeration Data. 2011,” Gov. India, no. July, 2014.
21 Mahanta B. , Mohapatra P. K. , Phukan N. , and Mahanta J. , “Alcohol use among school-going adolescent boys and girls in an industrial town of Assam, India,” Indian J. Psychiatry, vol. 58 , no. 2 , p. 157, 2016. doi: 10.4103/0019-5545.183784 27385848
22 Medhi G. K. , Hazarika N. C. , and Mahanta J. , “Correlates of alcohol consumption and tobacco use among tea industry workers of Assam,” Subst. Use Misuse, vol. 41 , no. 5 , pp. 691–706, 2006. doi: 10.1080/10826080500411429 16603455
23 Saikia N. and Debbarma B. , “The socioeconomic correlates of substance use among male adults in Northeast India,” Clin. Epidemiol. Glob. Heal., vol. 8 , no. 1 , pp. 149–157, 2020, doi: 10.1016/j.cegh.2019.06.004
24 Misra P. J. , Mini G. K. , and Thankappan K. R. , “Risk factor profile for non-communicable diseases among Mishing tribes in Assam, India: Results from a WHO STEPs survey,” Indian J. Med. Res., vol. 140 , no. 3 , p. 370, 2014. 25366204
25 Rahaman M. , Roy A. , Kapasia N. , and Chouhan P. , “Prevalence and predictors of current tobacco exposure among older adults with chronic disease in India: evidence from large-scale sample survey,” J. Subst. Use, pp. 1–9, doi: 10.1080/14659891.2022.2146014
26 Chaturvedi H. K. , Phukan R. K. , and Mahanta J. , “The Association of Selected Sociodemographic Factors and Differences in Patterns of Substance Use: A Pilot Study in Selected Areas of Northeast India,” Subst. Use Misuse, vol. 38 , no. 9 , pp. 1305–1322, Jan 2003, doi: 10.1081/ja-120018488 12908813
27 Ladusingh L. , Dhillon P. , and Narzary P. K. , “Why Do the Youths in Northeast India Use Tobacco?,” J. Environ. Public Health, vol. 2017 , p. 1391253, 2017, doi: 10.1155/2017/1391253 28642795
28 Bhise M. D. , Patra S. , and Chaudhary M. , “Geographical variation in prevalence of non-communicable diseases (NCDs) and its correlates in India: evidence from recent NSSO survey,” J. Public Health (Bangkok)., vol. 26 , no. 5 , pp. 559–567, 2018.
29 Ngangbam S. and Roy A. K. , “Determinants of health-seeking behaviour in Northeast India,” J. Health Manag., vol. 21 , no. 2 , pp. 234–257, 2019.
30 Singh A. and Ladusingh L. , “Prevalence and determinants of tobacco use in India: Evidence from recent global adult tobacco survey data,” PLoS One, vol. 9 , no. 12 , pp. 1–18, 2014, doi: 10.1371/journal.pone.0114073 25474196
31 King J. E. , “Binary logistic regression,” Best Pract. Quant. methods, pp. 358–384, 2008.
32 Rehm J. and Probst C. , “Decreases of life expectancy despite decreases in non-communicable disease mortality: the role of substance use and socioeconomic status,” Eur. Addict. Res., vol. 24 , no. 2 , pp. 53–59, 2018. doi: 10.1159/000488328 29627831
33 Gupta R. , “Smoking, educational status & health inequity in India,” Indian J. Med. Res., vol. 124 , no. 1 , p. 15, 2006.16926453
34 A. M. John RM, Rout SK, Kumar BR, “Report on Economic Burdent of Tobacco Related Diseases in India.pdf,” New Delhi: Ministry of Health and Family Welfare, Government of India. pp. 15–18, 2014. [Online]. https://nhm.gov.in/NTCP/Surveys-Reports-Publications/Economic_Burden_of_Tobacco_Related_Diseases_in_India-Report.pdf
35 Patrick M. E. , Wightman P. , Schoeni R. F. , and Schulenberg J. E. , “Socioeconomic status and substance use among young adults: a comparison across constructs and drugs,” J. Stud. Alcohol Drugs, vol. 73 , no. 5 , pp. 772–782, 2012. doi: 10.15288/jsad.2012.73.772 22846241
36 McHugh R. K. , Votaw V. R. , Sugarman D. E. , and Greenfield S. F. , “Sex and gender differences in substance use disorders,” Clin. Psychol. Rev., vol. 66 , pp. 12–23, 2018. doi: 10.1016/j.cpr.2017.10.012 29174306
37 M. K. Gupta, D. A. Nagdeve, D. Mahata, and H. Chaurasia, “Substance Abuse Among Elderly in India: Evidence Based on Study on Global Ageing and Adult Health (SAGE) Wave 1,” Glob. Soc. Welf., pp. 1–7, 2023.
38 Bhan N. et al. , “Are socioeconomic disparities in tobacco consumption increasing in India? A repeated cross-sectional multilevel analysis,” BMJ Open, vol. 2 , no. 5 , p. e001348, Jan 2012, doi: 10.1136/bmjopen-2012-001348 23024253
39 Tomar S. P. , Kasar P. K. , Tiwari R. , Rajpoot S. S. , and Nayak S. , “Study of alcohol consumption and its sociodemographic determinants in a tribal village in Mandla district,” Int. J. Med. Sci. Public Heal., vol. 5 , no. 5 , pp. 989–993, 2016.
40 Giri S. et al. , “Consumption pattern and genotoxic potential of various smokeless tobacco products in Assam, India: A public health concern,” Mutat. Res. Toxicol. Environ. Mutagen., vol. 866 , p. 503349, 2021, doi: 10.1016/j.mrgentox.2021.503349 33985693
41 Shahbabu B. , Dasgupta A. , Sarkar I. , and Sarkar K. , “Rural-urban differentials in predicting tobacco consumption pattern among males above 15 years: A cross-sectional community survey,” Med. J. Dr. DY Patil Vidyapeeth, vol. 13 , no. 2 , p. 143, 2020.
42 Marbaniang S. P. , Chungkham H. S. , and Lhungdim H. , “A structured additive modeling of diabetes and hypertension in Northeast India,” PLoS One, vol. 17 , no. 1 , p. e0262560, 2022. doi: 10.1371/journal.pone.0262560 35025967
43 M. A. Kumar MS, Oinam A, Mukherjee D, Kishore K, “Women who use drugs in NorthEast India,” vol. 25, no. 4, pp. 343–349, 2015, [Online]. https://www.unodc.org/documents/southasia//publications/research-studies/FINAL_REPORT.pdf
44 Muksor A. , Dixit P. , and Varun M. R. , “Rural-Urban Differentials in NCD Multimorbidity in Adult Population in India: Prevalence and Cost of Care,” J Trop Med Heal. JTMH-121. vol. 10 , 2018.
45 Mishra V. K. , Srivastava S. , Muhammad T. , and V Murthy P. , “Relationship between tobacco use, alcohol consumption and non-communicable diseases among women in India: evidence from National Family Health Survey-2015-16,” BMC Public Health, vol. 22 , no. 1 , p. 713, 2022, doi: 10.1186/s12889-022-13191-z 35410193
46 Yang F. and Gu D. , “Widowhood, widowhood duration, and loneliness among older adults in China,” Soc. Sci. Med., vol. 283 , p. 114179, 2021. doi: 10.1016/j.socscimed.2021.114179 34225038
47 Sugathan T. N. , Soman C. R. , and Sankaranarayanan K. , “Behavioural risk factors for non communicable diseases among adults in Kerala, India.,” Indian J. Med. Res., vol. 127 , no. 6 , 2008. 18765874
48 Tushi A. , Rao S. R. , Pattabi K. , and Kaur P. , “Prevalence of risk factors for noncommunicable diseases in a rural tribal population of Mokokchung, Nagaland, India,” Natl. Med. J. India, vol. 31 , no. 1 , pp. 11–14, 2018. doi: 10.4103/0970-258X.243405 30348915
49 Bratzler D. W. , Oehlert W. H. , and Austelle A. , “Smoking in the elderly—it’s never too late to quit.,” J. Okla. State Med. Assoc., vol. 95 , no. 3 , pp. 185–191, 2002. 11921870
50 Gururaj G. , Gautham M. S. , and Arvind B. A. , “Alcohol consumption in India: A rising burden and a fractured response,” Drug Alcohol Rev., vol. 40 , no. 3 , pp. 368–384, 2021. doi: 10.1111/dar.13179 33000887
51 Ministry of Health & Family and G. O. India, “National Programme for prevention & Control of Cancer, Diabetes, Cardiovascular Diseases & stroke (NPCDCS),” Ministry of Health & Family welfare Government Of India, 2019. https://nhm.gov.in/index1.php?lang1&level=2&sublinkid=1048&lid=604
52 World Health Organization. Alcohol control policies in the South-East Asia region: selected issues. No. Alcohol Control Series-3. WHO Regional Office for South-East Asia, 2006.
53 Kaur J. and Jain D. C. , “Tobacco control policies in India: implementation and challenges.,” Indian J. Public Health, vol. 55 , no. 3 , pp. 220–227, 2011, doi: 10.4103/0019-557X.89941 22089690
54 Poduthase H. and Vellappally A. J. , “Alcohol Policies in India and United States : A Comparative Policy Analysis,” Int. J. Educ. Cult. Soc., vol. 1 , no. 2 , pp. 66–69, 2016, doi: 10.11648/j.ijecs.20160102.16
55 John R. M. , “Tobacco consumption patterns and its health implications in India,” Health Policy (New. York)., vol. 71 , no. 2 , pp. 213–222, 2005, doi: 10.1016/j.healthpol.2004.08.008 15607383
56 Jarvis M. J. , Wardle J. , Waller J. , and Owen L. , “Prevalence of hardcore smoking in England, and associated attitudes and beliefs: cross sectional study,” Bmj, vol. 326 , no. 7398 , p. 1061, 2003. doi: 10.1136/bmj.326.7398.1061 12750206
57 Orleans C. T. , Jepson C. , Resch N. , and Rimer B. K. , “Quitting motives and barriers among older smokers. The 1986 Adult Use of Tobacco Survey revisited,” Cancer, vol. 74 , no. S7 , pp. 2055–2061, 1994. doi: 10.1002/1097-0142(19941001)74:7+&lt;2055::aid-cncr2820741712&gt;3.0.co;2-q 8087771
